Anocca
Anocca AB provides services like Biotechnology, Immunotherapeutics, Drug Discovery, Drug Development, Immunology.
Anocca has raised €104M across 3 funding rounds from 11 investors, most recently a round in Aug 2025. Based in Södertälje, Sweden; active in Healthtech. Data as of 28 Oct 2026.
Södertälje, Swedenwww.anocca.com ↗
Total raised
€104M
€104,481,590
Funding rounds
3
Investors
11
distinct backers
Active since
2021-08
latest 2025-08
Funding by year
EUR raised per yearAnocca — funding by year — interactive chart.
Data table
| Anocca — funding by year | |
|---|---|
| 2021 | €40M |
| 2022 | €25M |
| 2025 | €39M |
Signals
High confidenceRaise-next likelihood48
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood24
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 5y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-08-20 | Other | €39M | AMF,Existing Shareholders,Mellby Gård,new investors,Ramsbury Invest | View deal → |
| 2022-12-21 | Debt | €25M | European Investment Bank | View deal → |
| 2021-08-03 | Series B | €40M | Harald Mix,Mellby Gård,Michano,Nidoco,Ramsbury Invest,Robert Andreen+1 more | View deal → |
Investors
11Related news
- Anocca Secures EUR 25M from the European Investment Bankfinsmes.com · 2022-12
- Sweden’s Anocca raises €40M to develop novel therapeutics for cancer, infectious disease, autoimmunitysiliconcanals.com · 2021-08
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData